Association of Serum Kynurenine Levels and Neural Networks in Patients with First-Episode, Drug-Naïve Major Depression: A Source-Based Morphometry Study

References

• Malhi GS, Mann JJ. Depression. Lancet. 2018;392(10161):2299–2312. doi:10.1016/S0140-6736(18)31948-230396512
   PubMed Web of Science ®Google Scholar
• Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22–34.26711676
   PubMed Web of Science ®Google Scholar
• Bollen J, Trick L, Llewellyn D, Dickens C. The effects of acute inflammation on cognitive functioning and emotional processing in humans: a systematic review of experimental studies. J Psychol Res. 2017;94:47–55. doi:10.1016/j.jpsychores.2017.01.002
   Web of Science ®Google Scholar
• Perry VH, Nicoll JA, Holmes C. Microglia in neurodegenerative disease. Nat Rev Neurol. 2010;6(4):193–201. doi:10.1038/nrneurol.2010.1720234358
   PubMed Web of Science ®Google Scholar
• Miller AH, Maletic V, Raison CL. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol Psychiatry. 2009;65(9):732–741. doi:10.1016/j.biopsych.2008.11.02919150053
   PubMed Web of Science ®Google Scholar
• Goldsmith DR, Rapaport MH, Miller BJ. A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression. Mol Psychiatry. 2016;21(12):1696–1709. doi:10.1038/mp.2016.326903267
   PubMed Web of Science ®Google Scholar
• Ogyu K, Kubo K, Noda Y, et al. Kynurenine pathway in depression: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2018;90:16–25. doi:10.1016/j.neubiorev.2018.03.02329608993
   PubMed Web of Science ®Google Scholar
• Bay-Richter C, Linderholm KR, Lim CK, et al. A role for inflammatory metabolites as modulators of the glutamate N-methyl-D-aspartate receptor in depression and suicidality. Brain Behav Immun. 2015;43:110–117. doi:10.1016/j.bbi.2014.07.01225124710
   PubMed Web of Science ®Google Scholar
• Dantzer R, O’Connor JC, Lawson MA, Kelley KW. Inflammation-associated depression: from serotonin to kynurenine. Psychoneuroendocrinology. 2011;36(3):426–436. doi:10.1016/j.psyneuen.2010.09.01221041030
   PubMed Web of Science ®Google Scholar
• Oxenkrug GF. Metabolic syndrome, age-associated neuroendocrine disorders, and dysregulation of tryptophan—kynurenine metabolism. Ann N Y Acad Sci. 2010;1199:1–14. doi:10.1111/j.1749-6632.2009.05356.x20633104
   PubMed Web of Science ®Google Scholar
• Müller N, Schwarz MJ. COX-2 inhibition in schizophrenia and major depression. Curr Pharm Des. 2008;14(14):1452–1465. doi:10.2174/13816120878448024318537668
   PubMed Web of Science ®Google Scholar
• Schwarcz R, Bruno JP, Muchowski PJ, Wu HQ. Kynurenines in the mammalian brain: when physiology meets pathology. Nat Rev Neurosci. 2012;13(7):465–477.22678511
   PubMed Web of Science ®Google Scholar
• Walker AK, Budac DP, Bisulco S, et al. NMDA receptor blockade by ketamine abrogates lipopolysaccharide-induced depressive-like behavior in C57BL/6J mice. Neuropsychopharmacology. 2013;38(9):1609–1616. doi:10.1038/npp.2013.7123511700
   PubMed Web of Science ®Google Scholar
• Baranyi A, Meinitzer A, Breitenecker RJ, Amouzadeh-Ghadikolai O, Stauber R, Rothenhäusler HB. Quinolinic acid responses during interferon-α-induced depressive symptomatology in patients with chronic hepatitis c infection - a novel aspect for depression and inflammatory hypothesis. PLoS One. 2015;10(9):e0137022. doi:10.1371/journal.pone.013702226368809
   PubMed Web of Science ®Google Scholar
• Bonaccorso S, Marino V, Puzella A, et al. Increased depressive ratings in patients with hepatitis C receiving interferon-α-based immunotherapy are related to interferon-α -induced changes in the serotonergic system. J Clin Psychopharmacol. 2002;22(1):86–90. doi:10.1097/00004714-200202000-0001411799348
   PubMed Web of Science ®Google Scholar
• Capuron L, Neurauter G, Musselman DL, et al. Interferon-alpha-induced changes in tryptophan metabolism: relationship to depression and paroxetine treatment. Biol Psychiatry. 2003;54(9):906–914. doi:10.1016/S0006-3223(03)00173-214573318
   PubMed Web of Science ®Google Scholar
• Stone TW, Perkins MN. Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS. Eur J Pharmacol. 1981;72(4):411–412. doi:10.1016/0014-2999(81)90587-26268428
   PubMed Web of Science ®Google Scholar
• Guillemin GJ, Croitoru-Lamoury J, Dormont D, Armati PJ, Brew BJ. Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes. Glia. 2003;41(4):371–381. doi:10.1002/glia.1017512555204
   PubMed Web of Science ®Google Scholar
• Savitz J, Drevets WC, Smith CM, et al. Putative neuroprotective and neurotoxic kynurenine pathway metabolites are associated with hippocampal and amygdala volumes in subjects with major depressive disorder. Neuropsychopharmacology. 2015;40(2):463–471. doi:10.1038/npp.2014.19425074636
   PubMed Web of Science ®Google Scholar
• Doolin K, Allers KA, Pleiner S, et al. Altered tryptophan catabolite concentrations in major depressive disorder and associated changes in hippocampal subfield volumes. Psychoneuroendocrinology. 2018;95:8–17. doi:10.1016/j.psyneuen.2018.05.01929787958
   PubMed Web of Science ®Google Scholar
• DeWitt SJ, Bradley KA, Lin N, Yu C, Gabbay V. A pilot resting-state functional connectivity study of the kynurenine pathway in adolescents with depression and healthy controls. J Affect Disord. 2018;227:752–758. doi:10.1016/j.jad.2017.11.04029254065
   PubMed Web of Science ®Google Scholar
• Dai L, Zhou H, Xu X, Zuo Z. Brain structural and functional changes in patients with major depressive disorder: a literature review. PeerJ. 2019;7:e8170. doi:10.7717/peerj.817031803543
   PubMed Web of Science ®Google Scholar
• Watanabe K, Kakeda S, Katsuki A, et al. Whole-brain structural covariance network abnormality in first-episode and drug-naïve major depressive disorder. Psychiatry Res Neuroimaging. 2020;300:111083. doi:10.1016/j.pscychresns.2020.11108332298948
   PubMed Web of Science ®Google Scholar
• Okusaga O, Duncan E, Langenberg P, et al. Combined toxoplasma gondii seropositivity and high blood kynurenine—linked with nonfatal suicidal self-directed violence in patients with schizophrenia. J Psychiatr Res. 2016;72:74–81. doi:10.1016/j.jpsychires.2015.10.00226594873
   PubMed Web of Science ®Google Scholar
• Kita T, Morrison PF, Heyes MP, Markey SP. Effects of systemic and central nervous system localized inflammation on the contributions of metabolic precursors to the L-kynurenine and quinolinic acid pools in brain. J Neurochem. 2002;82(2):258–268. doi:10.1046/j.1471-4159.2002.00955.x12124427
   PubMed Web of Science ®Google Scholar
• Colín-González AL, Maldonado PD, Santamaría A. 3-hydroxykynurenine: an intriguing molecule exerting dual actions in the central nervous system. Neurotoxicology. 2013;34:189–204. doi:10.1016/j.neuro.2012.11.00723219925
   PubMed Web of Science ®Google Scholar
• Johansson AS, Owe-Larsson B, Asp L, et al. Activation of kynurenine pathway in ex vivo fibroblasts from patients with bipolar disorder or schizophrenia: cytokine challenge increases production of 3-hydroxykynurenine. J Psychiatr Res. 2013;47(11):1815–1823. doi:10.1016/j.jpsychires.2013.08.00824012176
   PubMed Web of Science ®Google Scholar
• Liu H, Ding L, Zhang H, et al. The metabolic factor kynurenic acid of kynurenine pathway predicts major depressive disorder. Front Psychiatry. 2018;9:552. doi:10.3389/fpsyt.2018.0055230510519
   PubMed Web of Science ®Google Scholar
• Kakeda S, Watanabe K, Katsuki A, et al. Relationship between interleukin (IL)-6 and brain morphology in drug-naïve, first-episode major depressive disorder using surface-based morphometry. Sci Rep. 2018;8:10054. doi:10.1038/s41598-018-28300-529968776
   PubMed Web of Science ®Google Scholar
• Sugimoto K, Kakeda S, Watanabe K, et al. Relationship between white matter integrity and serum inflammatory cytokine levels in drug-naive patients with major depressive disorder: diffusion tensor imaging study using tract-based spatial statistics. Transl Psychiatry. 2018;8(1):1–8. doi:10.1038/s41398-018-0174-y29317594
   PubMed Web of Science ®Google Scholar
• Menon V, Uddin LQ. Saliency, switching, attention and control: a network model of insula function. Brain Struct Funct. 2010;214(5–6):655–667. doi:10.1007/s00429-010-0262-020512370
   PubMed Web of Science ®Google Scholar
• Goulden N, Khusnulina A, Davis NJ, et al. The salience network is responsible for switching between the default mode network and the central executive network: replication from DCM. Neuroimage. 2014;99:180–190. doi:10.1016/j.neuroimage.2014.05.05224862074
   PubMed Web of Science ®Google Scholar
• Admon R, Holsen LM, Aizley H, et al. Striatal hypersensitivity during stress in remitted individuals with recurrent depression. Biol Psychiatry. 2015;78(1):67–76. doi:10.1016/j.biopsych.2014.09.01925483401
   PubMed Web of Science ®Google Scholar
• Admon R, Pizzagalli DA. Corticostriatal pathways contribute to the natural time course of positive mood. Nat Commun. 2015;7(6):10065. doi:10.1038/ncomms10065
   Web of Science ®Google Scholar
• Fu CH, Steiner H, Costafreda SG. Predictive neural biomarkers of clinical response in depression: a meta-analysis of functional and structural neuroimaging studies of pharmacological and psychological therapies. Neurobiol Dis. 2013;52:75–83. doi:10.1016/j.nbd.2012.05.00822659303
   PubMed Web of Science ®Google Scholar
• Whitton AE, Webb CA, Dillon DG, et al. Pretreatment rostral anterior cingulate cortex connectivity with salience network predicts depression recovery: findings from the EMBARC randomized clinical trial. Biol Psychiatry. 2019;85(10):872–880. doi:10.1016/j.biopsych.2018.12.00730718038
   PubMed Web of Science ®Google Scholar
• Inoshita M, Umehara H, Watanabe SY, et al. Elevated peripheral blood glutamate levels in major depressive disorder. Neuropsychiatr Dis Treat. 2018;14:945–953. doi:10.2147/NDT.S15985529670355
   PubMed Web of Science ®Google Scholar
• Moriguchi S, Takamiya A, Noda Y, et al. Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies. Mol Psychiatry. 2019;24(7):952–964. doi:10.1038/s41380-018-0252-930315224
   PubMed Web of Science ®Google Scholar
• Duman RS, Sanacora G, Krystal JH. Altered connectivity in depression: GABA and glutamate neurotransmitter deficits and reversal by novel treatments. Neuron. 2019;102(1):75–90. doi:10.1016/j.neuron.2019.03.01330946828
   PubMed Web of Science ®Google Scholar
• Murrough JW, Abdallah CG, Mathew SJ. Targeting glutamate signaling in depression: progress and prospects. Nat Rev Drug Discov. 2017;16(7):472–486. doi:10.1038/nrd.2017.1628303025
   PubMed Web of Science ®Google Scholar
• Xu L, Groth KM, Pearlson G, Schretlen DJ, Calhoun VD. Source-based morphometry: the use of independent component analysis to identify gray matter differences with application to schizophrenia. Hum Brain Mapp. 2009;30(3):711–724. doi:10.1002/hbm.2054018266214
   PubMed Web of Science ®Google Scholar
• American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington DC: American Psychiatric Association; 2000.
   Google Scholar
• Hamilton M. Development of a rating scale for primary depressive illness. Br J Soc Clin Psychol. 1967;6(4):278–296. doi:10.1111/j.2044-8260.1967.tb00530.x6080235
   PubMedGoogle Scholar
• Soga T, Heiger DN. Amino acid analysis by capillary electrophoresis electrospray ionization mass spectrometry. Anal Chem. 2000;72(6):1236–1241. doi:10.1021/ac990976y10740865
   PubMed Web of Science ®Google Scholar
• Soga T, Ueno Y, Naraoka H, Ohashi Y, Tomita M, Nishioka T. Simultaneous determination of anionic intermediates for Bacillus subtilis metabolic pathways by capillary electrophoresis electrospray ionization mass spectrometry. Anal Chem. 2002;74:2233–2239. doi:10.1021/ac020064n12038746
   PubMed Web of Science ®Google Scholar
• Soga T, Ohashi Y, Ueno Y, Naraoka H, Tomita M, Nishioka T. Quantitative metabolome analysis using capillary electrophoresis mass spectrometry. J Proteome Res. 2003;2(5):488–494. doi:10.1021/pr034020m14582645
   PubMed Web of Science ®Google Scholar
• Sugimoto M, Wong DT, Hirayama A, Soga T, Tomita M. Capillary electrophoresis mass spectrometry-based saliva metabolomics identified oral, breast and pancreatic cancer–specific profiles. Metabolomics. 2010;6(1):78–95.20300169
   PubMed Web of Science ®Google Scholar
• Junker BH, Klukas C, Schreiber F. VANTED: a system for advanced data analysis and visualization in the context of biological networks. BMC Bioinform. 2006;7(1):109. doi:10.1186/1471-2105-7-109
   PubMed Web of Science ®Google Scholar
• Jovicich J, Czanner S, Greve D, et al. Reliability in multi-site structural MRI studies: effects of gradient non-linearity correction on phantom and human data. Neuroimage. 2006;30(2):436–443. doi:10.1016/j.neuroimage.2005.09.04616300968
   PubMed Web of Science ®Google Scholar
• Sled JG, Zijdenbos AP, Evans AC. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans Med Imaging. 1998;17(1):87–97. doi:10.1109/42.6686989617910
   PubMed Web of Science ®Google Scholar
• Kanda Y. Investigation of the freely available easy-to-use software ‘EZR’ for medical statistics. Bone Marrow Transplant. 2013;48(3):452–458.23208313
   PubMed Web of Science ®Google Scholar